EUVIMEDEUVIMED entdecken
Beobachtungsstudie

A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3

Marta Novella-Navarro, Jose Luis Cabrera-Alarcon, Cesar Diaz-Torne, Francisco Aramburu-Muñoz, Iustina Janta, Maria Carmen Ortega de la O, Alejandro Prada-Ojeda, Luis Sala-Icardo, Ana Urruticoechea-Arana, Paloma García de la Peña Lefebvre, Enrique Calvo-Aranda

Rheumatology International · 2020-07 · 40 (7) · 1081-1087

DOI: 10.1007/s00296-020-04517-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Rheumatology International, online erschienen am 25.01.2020. Verfasst von Marta Novella-Navarro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Hospital Universitario Torrejon de Ardoz, Madrid, Spain. Hauptthemen laut MEDLINE: Glomerular Filtration Rate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerular Filtration RateAgedAged, 80 and overAlcohol DrinkingAllopurinolColchicineFebuxostatFemaleGoutGout SuppressantsHumansLinear ModelsMaleMiddle AgedPatient Care PlanningRenal Insufficiency, ChronicRetrospective StudiesSmokingTreatment OutcomeUric AcidXanthine Oxidase

Stichwörter der Autor:innen

ChronicGoutRenal insufficiencyRenoprotectiveTreat-to-targetXanthine oxidase antagonistsXanthine oxidase inhibitors

Substanzen

Gout SuppressantsFebuxostatUric AcidAllopurinolXanthine OxidaseColchicine

Autor:innen und Institutionen

  • Rheumatology Department, Hospital Universitario Torrejon de Ardoz, Madrid, Spain.
  • Crystal-induced Arthritis Study Group, Spanish Society of Rheumatology (GEACSER), Madrid, Spain.
  • Bioinformatic Unit/GENOXPHOS-Group, Centro Nacional Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
  • Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Rheumatology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Rheumatology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.

Zitieren

APA

Novella-Navarro, M., Cabrera-Alarcon, J. L., Diaz-Torne, C., Aramburu-Muñoz, F., Janta, I., Ortega de la O, M. C., Prada-Ojeda, A., Sala-Icardo, L., Urruticoechea-Arana, A., García de la Peña Lefebvre, P., & Calvo-Aranda, E. (2020). A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3. Rheumatology International, 40(7), 1081-1087. https://doi.org/10.1007/s00296-020-04517-4

Vancouver

Novella-Navarro M, Cabrera-Alarcon JL, Diaz-Torne C, Aramburu-Muñoz F, Janta I, Ortega de la O MC, et al. A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3. Rheumatology International. 2020;40(7):1081-1087. doi:10.1007/s00296-020-04517-4

BibTeX
@article{NovellaNavarro2020,
  author = {Novella-Navarro, Marta and Cabrera-Alarcon, Jose Luis and Diaz-Torne, Cesar and Aramburu-Muñoz, Francisco and Janta, Iustina and Ortega de la O, Maria Carmen and Prada-Ojeda, Alejandro and Sala-Icardo, Luis and Urruticoechea-Arana, Ana and García de la Peña Lefebvre, Paloma and Calvo-Aranda, Enrique},
  title = {A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3},
  journal = {Rheumatology International},
  year = {2020},
  volume = {40},
  number = {7},
  pages = {1081--1087},
  doi = {10.1007/s00296-020-04517-4}
}
Kostenlos starten →